Oncolytics Biotech® to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026
Go back to Oncolytics Biotech® to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.94 -0.02 (2.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.96 | 52 Week High | $1.37 | |||
| Open | $0.99 | 52 Week Low | $0.24 | |||
| Day High | $1.02 | P/E | N/A | |||
| Day Low | $0.93 | EPS | $0.00 | |||
| Volume | 592,176 | |||||
